ESTRO
2015
Healthy
tissues
Tumor
Reduction of radiosensitivity differences
:
Potential therapeutic advantage
when the tumor is radioresistant
in comparison with healthy tissues
Potential therapeutic benefit due to the
reduction
of an
unfavourable
differential effect
Dose
(gamma)
Dose
(
neutrons)
Surviving Fractions (%)
Surviving Fractions (%)




